학술논문
Rational polypharmacological targeting of FLT3, JAK2, ABL, and ERK1 suppresses the adaptive resistance to FLT3 inhibitors in AML
Document Type
Article
Author
Source
In Blood Advances 25 April 2023 7(8):1460-1476
Subject
Language
ISSN
2473-9529